Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos III
Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos III is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 1 of 1 trials · Latest update first
Patient-Centered Study of Trastuzumab Deruxtecan (T-DXd) in First-Line HER2-Positive Metastatic Breast Cancer with Proactive Toxicity Management Reflecting Real-World Clinical Practice / TOP-REAL Trial
Sponsor Solti Group
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos III?
The 2026-10-09 snapshot links Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos III to 1 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos III?
The most frequently recorded therapeutic areas are Solid Tumor Oncology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos III conducted?
The linked trials record locations in 3 countries, including Germany, Spain, France. These are trial locations, not confirmed office locations or countries where Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos III delivered services.
What can this page tell me about Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos III's trial experience?
Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos III. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos III